Cite
APA Citation
Rugo, H., O'Shaughnessy, J., Song, C., Broom, R., Gumus, M., Yamashita, T., San Antonio, B., Shahir, A., Zimmermann, A., Zagouri, F., & Reinisch, M. (n.d.). safety outcomes from monarchE: Phase 3 study of abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER-2-, node-positive, high risk, early breast cancer. Breast, 56, S23–S24. http://access.bl.uk/ark:/81055/vdc_100123988441.0x000025